Global brain water increases after experimental focal cerebral ischemia: Effect of hypertonic saline

OBJECTIVE Isolated experiments suggest that global cerebral edema is a sequela of large hemispheric ischemic lesions, presumably as an extension of the initial ischemic insult into areas of vital, noninjured tissue. Diuretics and osmotic agents are controversial and poorly defined therapeutic modali...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 2002-03, Vol.30 (3), p.644-649
Hauptverfasser: Toung, Thomas J. K, Hurn, Patricia D, Traystman, Richard J, Bhardwaj, Anish
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 649
container_issue 3
container_start_page 644
container_title Critical care medicine
container_volume 30
creator Toung, Thomas J. K
Hurn, Patricia D
Traystman, Richard J
Bhardwaj, Anish
description OBJECTIVE Isolated experiments suggest that global cerebral edema is a sequela of large hemispheric ischemic lesions, presumably as an extension of the initial ischemic insult into areas of vital, noninjured tissue. Diuretics and osmotic agents are controversial and poorly defined therapeutic modalities after large infarction. By using a rat model of middle cerebral artery occlusion ( MCAO ), we tested the hypothesis that significant edema occurs in the contralateral uninjured hemisphere and that this postischemic complication can be manipulated by hypertonic saline therapy. DESIGN Prospective laboratory animal study. SETTING Research laboratory in a teaching hospital. SUBJECTS Halothane-anesthetized, male Wistar rats. INTERVENTIONS Under controlled conditions of normoxia, normocarbia, and normothermia, rats were subjected to 2 hrs of MCAO. MEASUREMENTS AND MAIN RESULTS Adequacy of MCAO and reperfusion was assessed by laser Doppler flowmetry. All animals except naive rats received continuous infusion of 0.9% saline at 0.5 mL/hr throughout the experiment. Brains were harvested, and tissue water content was estimated by comparing the wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 12 hrs, 24 hrs, or 2, 3, or 7 days postischemia. Naive and sham-operated rats served as control cohorts. In a second series of randomized experiments, wet-to-dry weight ratios were determined in rats treated with continuous intravenous infusion of 7.5% hypertonic saline (0.5 mL/hr; acetate/chloride, 50:50) and were compared with well-studied antiedema therapy20 % mannitol (2.5 g/kg bolus every 6 hrs) or furosemide (2.5 mg/kg bolus every 6 hrs). Treatments were started at 24 hrs of reperfusion, and brain water was assessed at 2 days of reperfusion. In a third series of experiments, wet-to-dry ratios were determined in brains harvested at 2 days of reperfusion from rats that were subjected to 2 hrs of MCAO and did not receive any intravenous fluids. All values are mean ± sem. There were no differences between sham-operated and naive control cohorts. At 24 hrs of reperfusion, water content was higher in both ipsilateral ischemic (82.80 ± 0.86%) and contralateral hemispheres (80.53 ± 0.29%), compared with naive animals (ipsilateral, 79.62 ± 0.12%; contralateral, 79.53 ± 0.13%). Maximal cerebral edema was measured at 2 days in both hemispheres (ipsilateral, 83.94 ± 0.47%; contralateral, 80.63 ± 0.13%). Edema was present for up to 3 days in contralateral
doi_str_mv 10.1097/00003246-200203000-00025
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71652738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71652738</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4815-b5e582e273358fb4615f6c350e9a48f95e7756702fec224f8332dfc3790cc06b3</originalsourceid><addsrcrecordid>eNp1kUtPGzEQgK0KVFLav1D5Arel49d6za1CPCoh9VLOltcZK9s6u6m9Ucq_ZyABTrVkj0b6Zsb-zBgXcCHA2W9AS0ndNhJAgqKsoS3NB7YQRlEinTpiCwAHjdJOnbBPtf4GENpY9ZGdCOEcONkt2PI2T33IvC9hGPkuzFj4MMaCoWLlIT3n-G-DZVjjOBOYpkhnxIJUkvlQ4wrXQ7jk1ylhnPmU-OqR-Hkah8hryMOIn9lxCrnil0M8ZQ8317-u7pr7n7c_rr7fN1F3wjS9QdNJlFYp06Vet8KkNioD6ILukjNorWktSBokpU6dUnKZorIOYoS2V6fsfN93U6a_W6yzX9P9MOcw4rSt3orWUPeOwG4PxjLVWjD5DT0wlEcvwD8b9q-G_Zth_2KYSr8eZmz7NS7fCw9KCTg7AKGSqlTCGIf6ziljhBaWOL3ndlMmy_VP3u6w-BWGPK_8_35YPQHZbpLP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71652738</pqid></control><display><type>article</type><title>Global brain water increases after experimental focal cerebral ischemia: Effect of hypertonic saline</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Toung, Thomas J. K ; Hurn, Patricia D ; Traystman, Richard J ; Bhardwaj, Anish</creator><creatorcontrib>Toung, Thomas J. K ; Hurn, Patricia D ; Traystman, Richard J ; Bhardwaj, Anish</creatorcontrib><description>OBJECTIVE Isolated experiments suggest that global cerebral edema is a sequela of large hemispheric ischemic lesions, presumably as an extension of the initial ischemic insult into areas of vital, noninjured tissue. Diuretics and osmotic agents are controversial and poorly defined therapeutic modalities after large infarction. By using a rat model of middle cerebral artery occlusion ( MCAO ), we tested the hypothesis that significant edema occurs in the contralateral uninjured hemisphere and that this postischemic complication can be manipulated by hypertonic saline therapy. DESIGN Prospective laboratory animal study. SETTING Research laboratory in a teaching hospital. SUBJECTS Halothane-anesthetized, male Wistar rats. INTERVENTIONS Under controlled conditions of normoxia, normocarbia, and normothermia, rats were subjected to 2 hrs of MCAO. MEASUREMENTS AND MAIN RESULTS Adequacy of MCAO and reperfusion was assessed by laser Doppler flowmetry. All animals except naive rats received continuous infusion of 0.9% saline at 0.5 mL/hr throughout the experiment. Brains were harvested, and tissue water content was estimated by comparing the wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 12 hrs, 24 hrs, or 2, 3, or 7 days postischemia. Naive and sham-operated rats served as control cohorts. In a second series of randomized experiments, wet-to-dry weight ratios were determined in rats treated with continuous intravenous infusion of 7.5% hypertonic saline (0.5 mL/hr; acetate/chloride, 50:50) and were compared with well-studied antiedema therapy20 % mannitol (2.5 g/kg bolus every 6 hrs) or furosemide (2.5 mg/kg bolus every 6 hrs). Treatments were started at 24 hrs of reperfusion, and brain water was assessed at 2 days of reperfusion. In a third series of experiments, wet-to-dry ratios were determined in brains harvested at 2 days of reperfusion from rats that were subjected to 2 hrs of MCAO and did not receive any intravenous fluids. All values are mean ± sem. There were no differences between sham-operated and naive control cohorts. At 24 hrs of reperfusion, water content was higher in both ipsilateral ischemic (82.80 ± 0.86%) and contralateral hemispheres (80.53 ± 0.29%), compared with naive animals (ipsilateral, 79.62 ± 0.12%; contralateral, 79.53 ± 0.13%). Maximal cerebral edema was measured at 2 days in both hemispheres (ipsilateral, 83.94 ± 0.47%; contralateral, 80.63 ± 0.13%). Edema was present for up to 3 days in contralateral tissue (80.27 ± 0.26%) and persisted to 7 days in the injured hemisphere (81.07 ± 0.34%). Maximal edema (as assessed at 2 days postocclusion) was robustly attenuated with hypertonic saline therapy (ipsilateral, 81.59 ± 0.52%; contralateral, 78.44 ± 0.22%). The efficacy of hypertonic saline was equivalent to furosemide (ipsilateral, 82.09 ± 0.50%; contralateral, 79.13 ± 0.17%) but less robust than mannitol (ipsilateral, 79.89 ± 0.36%; contralateral, 78.73 ± 0.17%). CONCLUSIONS These data demonstrate that cerebral edema persists in both injured and contralateral hemispheres for days after MCAO. The global, maximal increase in brain water is responsive to continuous 7.5% hypertonic saline treatment begun at 24 hrs postischemia and to standard diuretic/osmotic agents. These results may have implications for diuretic and osmotic therapy in clinical ischemic stroke.</description><identifier>ISSN: 0090-3493</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/00003246-200203000-00025</identifier><identifier>PMID: 11990928</identifier><identifier>CODEN: CCMDC7</identifier><language>eng</language><publisher>Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</publisher><subject>Analysis of Variance ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Brain Edema - drug therapy ; Brain Edema - etiology ; Brain Ischemia - complications ; Diuretics - pharmacology ; Diuretics - therapeutic use ; Diuretics, Osmotic - pharmacology ; Diuretics, Osmotic - therapeutic use ; Emergency and intensive care: comas and nervous system diseases ; Furosemide - pharmacology ; Furosemide - therapeutic use ; Infarction, Middle Cerebral Artery - complications ; Intensive care medicine ; Male ; Mannitol - pharmacology ; Mannitol - therapeutic use ; Medical sciences ; Rats ; Rats, Wistar ; Saline Solution, Hypertonic - pharmacology ; Saline Solution, Hypertonic - therapeutic use</subject><ispartof>Critical care medicine, 2002-03, Vol.30 (3), p.644-649</ispartof><rights>2002 by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4815-b5e582e273358fb4615f6c350e9a48f95e7756702fec224f8332dfc3790cc06b3</citedby><cites>FETCH-LOGICAL-c4815-b5e582e273358fb4615f6c350e9a48f95e7756702fec224f8332dfc3790cc06b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13551417$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11990928$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toung, Thomas J. K</creatorcontrib><creatorcontrib>Hurn, Patricia D</creatorcontrib><creatorcontrib>Traystman, Richard J</creatorcontrib><creatorcontrib>Bhardwaj, Anish</creatorcontrib><title>Global brain water increases after experimental focal cerebral ischemia: Effect of hypertonic saline</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>OBJECTIVE Isolated experiments suggest that global cerebral edema is a sequela of large hemispheric ischemic lesions, presumably as an extension of the initial ischemic insult into areas of vital, noninjured tissue. Diuretics and osmotic agents are controversial and poorly defined therapeutic modalities after large infarction. By using a rat model of middle cerebral artery occlusion ( MCAO ), we tested the hypothesis that significant edema occurs in the contralateral uninjured hemisphere and that this postischemic complication can be manipulated by hypertonic saline therapy. DESIGN Prospective laboratory animal study. SETTING Research laboratory in a teaching hospital. SUBJECTS Halothane-anesthetized, male Wistar rats. INTERVENTIONS Under controlled conditions of normoxia, normocarbia, and normothermia, rats were subjected to 2 hrs of MCAO. MEASUREMENTS AND MAIN RESULTS Adequacy of MCAO and reperfusion was assessed by laser Doppler flowmetry. All animals except naive rats received continuous infusion of 0.9% saline at 0.5 mL/hr throughout the experiment. Brains were harvested, and tissue water content was estimated by comparing the wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 12 hrs, 24 hrs, or 2, 3, or 7 days postischemia. Naive and sham-operated rats served as control cohorts. In a second series of randomized experiments, wet-to-dry weight ratios were determined in rats treated with continuous intravenous infusion of 7.5% hypertonic saline (0.5 mL/hr; acetate/chloride, 50:50) and were compared with well-studied antiedema therapy20 % mannitol (2.5 g/kg bolus every 6 hrs) or furosemide (2.5 mg/kg bolus every 6 hrs). Treatments were started at 24 hrs of reperfusion, and brain water was assessed at 2 days of reperfusion. In a third series of experiments, wet-to-dry ratios were determined in brains harvested at 2 days of reperfusion from rats that were subjected to 2 hrs of MCAO and did not receive any intravenous fluids. All values are mean ± sem. There were no differences between sham-operated and naive control cohorts. At 24 hrs of reperfusion, water content was higher in both ipsilateral ischemic (82.80 ± 0.86%) and contralateral hemispheres (80.53 ± 0.29%), compared with naive animals (ipsilateral, 79.62 ± 0.12%; contralateral, 79.53 ± 0.13%). Maximal cerebral edema was measured at 2 days in both hemispheres (ipsilateral, 83.94 ± 0.47%; contralateral, 80.63 ± 0.13%). Edema was present for up to 3 days in contralateral tissue (80.27 ± 0.26%) and persisted to 7 days in the injured hemisphere (81.07 ± 0.34%). Maximal edema (as assessed at 2 days postocclusion) was robustly attenuated with hypertonic saline therapy (ipsilateral, 81.59 ± 0.52%; contralateral, 78.44 ± 0.22%). The efficacy of hypertonic saline was equivalent to furosemide (ipsilateral, 82.09 ± 0.50%; contralateral, 79.13 ± 0.17%) but less robust than mannitol (ipsilateral, 79.89 ± 0.36%; contralateral, 78.73 ± 0.17%). CONCLUSIONS These data demonstrate that cerebral edema persists in both injured and contralateral hemispheres for days after MCAO. The global, maximal increase in brain water is responsive to continuous 7.5% hypertonic saline treatment begun at 24 hrs postischemia and to standard diuretic/osmotic agents. These results may have implications for diuretic and osmotic therapy in clinical ischemic stroke.</description><subject>Analysis of Variance</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Brain Edema - drug therapy</subject><subject>Brain Edema - etiology</subject><subject>Brain Ischemia - complications</subject><subject>Diuretics - pharmacology</subject><subject>Diuretics - therapeutic use</subject><subject>Diuretics, Osmotic - pharmacology</subject><subject>Diuretics, Osmotic - therapeutic use</subject><subject>Emergency and intensive care: comas and nervous system diseases</subject><subject>Furosemide - pharmacology</subject><subject>Furosemide - therapeutic use</subject><subject>Infarction, Middle Cerebral Artery - complications</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Mannitol - pharmacology</subject><subject>Mannitol - therapeutic use</subject><subject>Medical sciences</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Saline Solution, Hypertonic - pharmacology</subject><subject>Saline Solution, Hypertonic - therapeutic use</subject><issn>0090-3493</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtPGzEQgK0KVFLav1D5Arel49d6za1CPCoh9VLOltcZK9s6u6m9Ucq_ZyABTrVkj0b6Zsb-zBgXcCHA2W9AS0ndNhJAgqKsoS3NB7YQRlEinTpiCwAHjdJOnbBPtf4GENpY9ZGdCOEcONkt2PI2T33IvC9hGPkuzFj4MMaCoWLlIT3n-G-DZVjjOBOYpkhnxIJUkvlQ4wrXQ7jk1ylhnPmU-OqR-Hkah8hryMOIn9lxCrnil0M8ZQ8317-u7pr7n7c_rr7fN1F3wjS9QdNJlFYp06Vet8KkNioD6ILukjNorWktSBokpU6dUnKZorIOYoS2V6fsfN93U6a_W6yzX9P9MOcw4rSt3orWUPeOwG4PxjLVWjD5DT0wlEcvwD8b9q-G_Zth_2KYSr8eZmz7NS7fCw9KCTg7AKGSqlTCGIf6ziljhBaWOL3ndlMmy_VP3u6w-BWGPK_8_35YPQHZbpLP</recordid><startdate>200203</startdate><enddate>200203</enddate><creator>Toung, Thomas J. K</creator><creator>Hurn, Patricia D</creator><creator>Traystman, Richard J</creator><creator>Bhardwaj, Anish</creator><general>by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200203</creationdate><title>Global brain water increases after experimental focal cerebral ischemia: Effect of hypertonic saline</title><author>Toung, Thomas J. K ; Hurn, Patricia D ; Traystman, Richard J ; Bhardwaj, Anish</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4815-b5e582e273358fb4615f6c350e9a48f95e7756702fec224f8332dfc3790cc06b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Analysis of Variance</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Brain Edema - drug therapy</topic><topic>Brain Edema - etiology</topic><topic>Brain Ischemia - complications</topic><topic>Diuretics - pharmacology</topic><topic>Diuretics - therapeutic use</topic><topic>Diuretics, Osmotic - pharmacology</topic><topic>Diuretics, Osmotic - therapeutic use</topic><topic>Emergency and intensive care: comas and nervous system diseases</topic><topic>Furosemide - pharmacology</topic><topic>Furosemide - therapeutic use</topic><topic>Infarction, Middle Cerebral Artery - complications</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Mannitol - pharmacology</topic><topic>Mannitol - therapeutic use</topic><topic>Medical sciences</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Saline Solution, Hypertonic - pharmacology</topic><topic>Saline Solution, Hypertonic - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toung, Thomas J. K</creatorcontrib><creatorcontrib>Hurn, Patricia D</creatorcontrib><creatorcontrib>Traystman, Richard J</creatorcontrib><creatorcontrib>Bhardwaj, Anish</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toung, Thomas J. K</au><au>Hurn, Patricia D</au><au>Traystman, Richard J</au><au>Bhardwaj, Anish</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Global brain water increases after experimental focal cerebral ischemia: Effect of hypertonic saline</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>2002-03</date><risdate>2002</risdate><volume>30</volume><issue>3</issue><spage>644</spage><epage>649</epage><pages>644-649</pages><issn>0090-3493</issn><eissn>1530-0293</eissn><coden>CCMDC7</coden><abstract>OBJECTIVE Isolated experiments suggest that global cerebral edema is a sequela of large hemispheric ischemic lesions, presumably as an extension of the initial ischemic insult into areas of vital, noninjured tissue. Diuretics and osmotic agents are controversial and poorly defined therapeutic modalities after large infarction. By using a rat model of middle cerebral artery occlusion ( MCAO ), we tested the hypothesis that significant edema occurs in the contralateral uninjured hemisphere and that this postischemic complication can be manipulated by hypertonic saline therapy. DESIGN Prospective laboratory animal study. SETTING Research laboratory in a teaching hospital. SUBJECTS Halothane-anesthetized, male Wistar rats. INTERVENTIONS Under controlled conditions of normoxia, normocarbia, and normothermia, rats were subjected to 2 hrs of MCAO. MEASUREMENTS AND MAIN RESULTS Adequacy of MCAO and reperfusion was assessed by laser Doppler flowmetry. All animals except naive rats received continuous infusion of 0.9% saline at 0.5 mL/hr throughout the experiment. Brains were harvested, and tissue water content was estimated by comparing the wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 12 hrs, 24 hrs, or 2, 3, or 7 days postischemia. Naive and sham-operated rats served as control cohorts. In a second series of randomized experiments, wet-to-dry weight ratios were determined in rats treated with continuous intravenous infusion of 7.5% hypertonic saline (0.5 mL/hr; acetate/chloride, 50:50) and were compared with well-studied antiedema therapy20 % mannitol (2.5 g/kg bolus every 6 hrs) or furosemide (2.5 mg/kg bolus every 6 hrs). Treatments were started at 24 hrs of reperfusion, and brain water was assessed at 2 days of reperfusion. In a third series of experiments, wet-to-dry ratios were determined in brains harvested at 2 days of reperfusion from rats that were subjected to 2 hrs of MCAO and did not receive any intravenous fluids. All values are mean ± sem. There were no differences between sham-operated and naive control cohorts. At 24 hrs of reperfusion, water content was higher in both ipsilateral ischemic (82.80 ± 0.86%) and contralateral hemispheres (80.53 ± 0.29%), compared with naive animals (ipsilateral, 79.62 ± 0.12%; contralateral, 79.53 ± 0.13%). Maximal cerebral edema was measured at 2 days in both hemispheres (ipsilateral, 83.94 ± 0.47%; contralateral, 80.63 ± 0.13%). Edema was present for up to 3 days in contralateral tissue (80.27 ± 0.26%) and persisted to 7 days in the injured hemisphere (81.07 ± 0.34%). Maximal edema (as assessed at 2 days postocclusion) was robustly attenuated with hypertonic saline therapy (ipsilateral, 81.59 ± 0.52%; contralateral, 78.44 ± 0.22%). The efficacy of hypertonic saline was equivalent to furosemide (ipsilateral, 82.09 ± 0.50%; contralateral, 79.13 ± 0.17%) but less robust than mannitol (ipsilateral, 79.89 ± 0.36%; contralateral, 78.73 ± 0.17%). CONCLUSIONS These data demonstrate that cerebral edema persists in both injured and contralateral hemispheres for days after MCAO. The global, maximal increase in brain water is responsive to continuous 7.5% hypertonic saline treatment begun at 24 hrs postischemia and to standard diuretic/osmotic agents. These results may have implications for diuretic and osmotic therapy in clinical ischemic stroke.</abstract><cop>Hagerstown, MD</cop><pub>by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</pub><pmid>11990928</pmid><doi>10.1097/00003246-200203000-00025</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-3493
ispartof Critical care medicine, 2002-03, Vol.30 (3), p.644-649
issn 0090-3493
1530-0293
language eng
recordid cdi_proquest_miscellaneous_71652738
source MEDLINE; Journals@Ovid Complete
subjects Analysis of Variance
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Biological and medical sciences
Brain Edema - drug therapy
Brain Edema - etiology
Brain Ischemia - complications
Diuretics - pharmacology
Diuretics - therapeutic use
Diuretics, Osmotic - pharmacology
Diuretics, Osmotic - therapeutic use
Emergency and intensive care: comas and nervous system diseases
Furosemide - pharmacology
Furosemide - therapeutic use
Infarction, Middle Cerebral Artery - complications
Intensive care medicine
Male
Mannitol - pharmacology
Mannitol - therapeutic use
Medical sciences
Rats
Rats, Wistar
Saline Solution, Hypertonic - pharmacology
Saline Solution, Hypertonic - therapeutic use
title Global brain water increases after experimental focal cerebral ischemia: Effect of hypertonic saline
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T07%3A45%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Global%20brain%20water%20increases%20after%20experimental%20focal%20cerebral%20ischemia:%20Effect%20of%20hypertonic%20saline&rft.jtitle=Critical%20care%20medicine&rft.au=Toung,%20Thomas%20J.%20K&rft.date=2002-03&rft.volume=30&rft.issue=3&rft.spage=644&rft.epage=649&rft.pages=644-649&rft.issn=0090-3493&rft.eissn=1530-0293&rft.coden=CCMDC7&rft_id=info:doi/10.1097/00003246-200203000-00025&rft_dat=%3Cproquest_cross%3E71652738%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71652738&rft_id=info:pmid/11990928&rfr_iscdi=true